Back
Aldeyra Therapeutics Vs. Akebia Therapeutics Industry Stock Comparison
Sell
40
ALDX
Aldeyra Therapeutics
Last Price:
$4.87
Seasonality Move:
3.92%
Sell
39
AKBA
Akebia Therapeutics
Last Price:
$1.84
Seasonality Move:
7.91%
Sell
40
Aldeyra Therapeutics (ALDX)
is a Sell
Is Aldeyra Therapeutics a Buy, Sell or Hold?
-
The current Aldeyra Therapeutics [ALDX] share price is $4.86. The Score for ALDX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ALDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Akebia Therapeutics (AKBA)
is a Sell
Is Akebia Therapeutics a Buy, Sell or Hold?
-
The current Akebia Therapeutics [AKBA] share price is $1.84. The Score for AKBA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
AKBA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALDX Stock Price Chart
What is Aldeyra Therapeutics's stock price today?
-
The Aldeyra Therapeutics share price today is $4.86Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALDX is experiencing slight selling pressure.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.84The current trend is relatively stagnant and AKBA is experiencing slight buying pressure.
ALDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 45.9 | Sell |
Chaikin Money Flow: | -168401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.69 - 5.17) | Sell |
Bollinger Bands (100): | (4.58 - 5.8) | Sell |
AKBA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 46.96 | Sell |
Chaikin Money Flow: | 2456900 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.81 - 2.03) | Sell |
Bollinger Bands (100): | (1.31 - 1.85) | Buy |
ALDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.03 | Sell |
20-day SMA: | 5 | Sell |
50-day SMA: | 5.13 | Sell |
200-day SMA: | 4.47 | Buy |
8-day EMA: | 4.99 | Sell |
20-day EMA: | 5.01 | Sell |
50-day EMA: | 5.07 | Sell |
200-day EMA: | 4.79 | Buy |
AKBA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.84 | Sell |
20-day SMA: | 1.95 | Sell |
50-day SMA: | 1.79 | Buy |
200-day SMA: | 1.45 | Buy |
8-day EMA: | 1.85 | Sell |
20-day EMA: | 1.88 | Sell |
50-day EMA: | 1.79 | Buy |
200-day EMA: | 1.5 | Buy |
Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $0.48 per share.
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.
Aldeyra Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akebia Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |